Scarica l'app Stockscreener
1.79
1.10%
-0.02
Dopo l'orario di chiusura:
1.79
Precedente Chiudi:
$1.81
Aprire:
$1.8
Volume 24 ore:
603.00K
Relative Volume:
0.48
Capitalizzazione di mercato:
$113.23M
Reddito:
$139.77M
Utile/perdita netta:
$-97.62M
Rapporto P/E:
-1.1329
EPS:
-1.58
Flusso di cassa netto:
$-61.71M
1 W Prestazione:
+11.18%
1M Prestazione:
+34.59%
6M Prestazione:
+21.77%
1 anno Prestazione:
-46.57%
Intervallo 1D:
$1.75
$1.80
Intervallo di 1 settimana:
$1.58
$1.89
Portata 52W:
$0.9897
$3.365
Macrogenics Inc Stock (MGNX) Company Profile
Nome
Macrogenics Inc
Settore
Industria
Telefono
301-251-5172
Indirizzo
9704 MEDICAL CENTER DRIVE, Rockville, MD
Confronta MGNX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MGNX
Macrogenics Inc
|
1.79 | 114.50M | 139.77M | -97.62M | -61.71M | -1.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Macrogenics Inc Stock (MGNX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-09-17 | Ripresa | Barclays | Overweight |
| 2024-11-07 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-01 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-07-31 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2024-07-31 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-05-10 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2024-05-10 | Downgrade | Stifel | Buy → Hold |
| 2024-05-10 | Downgrade | TD Cowen | Buy → Hold |
| 2024-04-26 | Iniziato | B. Riley Securities | Buy |
| 2024-04-09 | Aggiornamento | TD Cowen | Hold → Buy |
| 2024-03-04 | Reiterato | BTIG Research | Buy |
| 2024-02-14 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2023-12-20 | Aggiornamento | Citigroup | Neutral → Buy |
| 2023-11-07 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2023-03-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2022-11-22 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-11-14 | Aggiornamento | BMO Capital Markets | Market Perform → Outperform |
| 2022-07-18 | Downgrade | SMBC Nikko | Outperform → Neutral |
| 2022-07-11 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| 2022-05-04 | Downgrade | Guggenheim | Buy → Neutral |
| 2022-02-28 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-02-11 | Iniziato | BMO Capital Markets | Outperform |
| 2022-02-04 | Iniziato | SMBC Nikko | Outperform |
| 2021-11-17 | Ripresa | Guggenheim | Buy |
| 2021-10-19 | Iniziato | JMP Securities | Mkt Outperform |
| 2021-10-15 | Ripresa | BTIG Research | Buy |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2021-03-12 | Aggiornamento | Barclays | Underweight → Overweight |
| 2020-12-22 | Ripresa | H.C. Wainwright | Buy |
| 2020-08-03 | Downgrade | Citigroup | Buy → Neutral |
| 2020-06-01 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2020-05-26 | Reiterato | H.C. Wainwright | Buy |
| 2020-03-04 | Iniziato | Barclays | Underweight |
| 2019-12-19 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-12-18 | Iniziato | Cantor Fitzgerald | Overweight |
| 2019-11-21 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2019-11-20 | Ripresa | Guggenheim | Neutral |
| 2019-05-03 | Aggiornamento | Wedbush | Neutral → Outperform |
| 2019-04-12 | Iniziato | Guggenheim | Neutral |
| 2019-02-07 | Aggiornamento | Citigroup | Sell → Buy |
| 2019-02-07 | Downgrade | Wedbush | Outperform → Neutral |
| 2019-02-06 | Aggiornamento | Raymond James | Underperform → Mkt Perform |
| 2019-02-04 | Downgrade | Citigroup | Neutral → Sell |
| 2018-12-10 | Downgrade | Raymond James | Outperform → Underperform |
| 2018-09-10 | Ripresa | BTIG Research | Buy |
| 2018-05-31 | Iniziato | Evercore ISI | Outperform |
| 2018-03-05 | Iniziato | H.C. Wainwright | Buy |
| 2017-03-31 | Iniziato | Raymond James | Outperform |
Mostra tutto
Macrogenics Inc Borsa (MGNX) Ultime notizie
How supply chain issues affect MacroGenics Inc. stockQuarterly Performance Summary & Weekly High Return Opportunities - ulpravda.ru
Will MacroGenics Inc. stock benefit from green energy trendsWeekly Profit Summary & High Accuracy Investment Signals - ulpravda.ru
Will MacroGenics Inc. stock gain from government policiesEarnings Overview Summary & Risk Controlled Swing Alerts - ulpravda.ru
There's No Escaping MacroGenics, Inc.'s (NASDAQ:MGNX) Muted Revenues Despite A 26% Share Price Rise - simplywall.st
MacroGenics (NASDAQ:MGNX) Cut to “Hold” at Zacks Research - Defense World
MacroGenics (NASDAQ:MGNX) Rating Lowered to "Hold" at Zacks Research - MarketBeat
MacroGenics (NASDAQ:MGNX) Shares Pass Above 50 Day Moving Average – Should You Sell? - Defense World
MacroGenics (NASDAQ:MGNX) Shares Pass Above 50 Day Moving AverageShould You Sell? - MarketBeat
MacroGenics, Inc. (NASDAQ:MGNX) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
MacroGenics, Inc. (NASDAQ:MGNX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Is MacroGenics Inc. stock positioned well for digital economyJuly 2025 Final Week & Weekly Breakout Watchlists - Улправда
Will MacroGenics Inc. stock attract more institutional investors2025 Growth vs Value & Technical Confirmation Alerts - DonanımHaber
MacroGenics, Inc.(NasdaqGS: MGNX) dropped from NASDAQ Biotechnology Index - marketscreener.com
How MacroGenics Inc. stock performs in rising dollar environment2025 Price Targets & Verified Swing Trading Watchlists - Улправда
Is MacroGenics Inc. stock a dividend growth opportunityJuly 2025 Action & Weekly Market Pulse Alerts - Улправда
MacroGenics Insider Ups Holding By 909% During Year - simplywall.st
Analyzing MacroGenics Stock: To Buy Or Wait? - StocksToTrade
EcoR1 Capital LLC Purchases New Shares in MacroGenics, Inc. $MGNX - MarketBeat
Will MacroGenics Inc stock attract more institutional investorsRecession Risk & Real-Time Volume Triggers - moha.gov.vn
MacroGenics (NASDAQ:MGNX) Stock Passes Below 200 Day Moving AverageHere's What Happened - MarketBeat
Reviewing MacroGenics (NASDAQ:MGNX) & Exagen (NASDAQ:XGN) - Defense World
Wall Street analysts’ outlook for Macrogenics Inc (MGNX) - setenews.com
What analysts say about MacroGenics Inc stockReal-Time Stock Alerts & Free Tremendous Portfolio Expansion - earlytimes.in
MacroGenics (NASDAQ:MGNX) Shares Cross Below 200-Day Moving AverageHere's What Happened - MarketBeat
MacroGenics (NASDAQ:MGNX) Shares Cross Below 200-Day Moving Average – Here’s What Happened - Defense World
IM Cannabis (NASDAQ:IMCC) & MacroGenics (NASDAQ:MGNX) Head to Head Survey - Defense World
Macrogenics (MGNX) Stock Analysis Report | Financials & Insights - Benzinga
MGNX (Macrogenics) EPS without NRI : $-1.20 (TTM As of Sep. 2025) - GuruFocus
MGNX (Macrogenics) Operating Cash Flow per Share : $-2.58 (TTM As of Sep. 2025) - GuruFocus
MacroGenics, Inc. (NASDAQ:MGNX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
MacroGenics, Inc. (NASDAQ:MGNX) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference - Enidnews.com
Taking the lead: Macrogenics Inc (MGNX) - Setenews
Is MacroGenics Inc. stock cheap at current valuationEarnings Recap Summary & High Conviction Buy Zone Picks - newser.com
Is MacroGenics Inc. stock positioned for digital transformation2025 AllTime Highs & Daily Volume Surge Trade Alerts - newser.com
Will MacroGenics Inc. stock recover faster than peersForecast Cut & Free Growth Oriented Trading Recommendations - newser.com
MacroGenics Announces Departure of Chief Medical Officer - The Globe and Mail
Why MacroGenics Inc. stock attracts high net worth investorsGap Up & Weekly Setup with High ROI Potential - newser.com
Is MacroGenics Inc. stock attractive for passive investorsLong Setup & Expert Verified Movement Alerts - newser.com
Will MacroGenics Inc. stock continue dividend increasesEarnings Recap Report & Long-Term Safe Investment Plans - newser.com
What MACD and RSI say about MacroGenics Inc.2025 Year in Review & Risk Managed Investment Entry Signals - newser.com
Automated trading signals detected on MacroGenics Inc.Inflation Watch & Safe Entry Point Identification - newser.com
Macrogenics Inc Azioni (MGNX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.80%
4.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):